Harmonic Pharma DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News

Nk Gen, Heka Bio Partner on Novel NK Cell Therapy

18 Jul 2025

// GLOBENEWSWIRE

Keros Therapeutics Doses First Patient in Phase 3 RENEW trial

18 Jul 2025

// GLOBENEWSWIRE

Sarepta Up 18% After Business Overhaul as Analysts Optimistic

18 Jul 2025

// BIOSPACE

DATA COMPILATION
#PharmaFlow

Contact Supplier

Website

APGA Annual Conference

Not Confirmed

Book a meeting

envelop Contact Supplier

Latest Content

radio-compass-blog/j-j-s-intra-cellular-buyout-bms-oncology-gambit-sanofi-s-blueprint-acquisition-drive-mega-deals-in-h1-2025

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

About

Harmonic Pharma has been founded in 2009 with a core technology dedicated to drug repurposing. The company has developed a platform to investigate the mechanism of action of any type of chemicals over the last years. Complementary AI-based solutions have been developed through the dual program entitled Chemical Range to provide public and private organizations with a more comprehensive toxicity profiling. December 2017, Seqens group announced his support to Harmonic Pharma through a capital increase. According to Pierre Luzeau, President of Seqens : “The access to Harmonic Pharma’s technology broadens Seqens’ services.